Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

HealthCor Catalio Acquisition (HCAQ) Competitors

HCAQ vs. CHEK, GEHC, HOLX, BFLY, NNOX, ALXO, EPIX, AVTE, SLS, and JATT

Should you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Check-Cap (CHEK), GE HealthCare Technologies (GEHC), Hologic (HOLX), Butterfly Network (BFLY), Nano-X Imaging (NNOX), ALX Oncology (ALXO), ESSA Pharma (EPIX), Aerovate Therapeutics (AVTE), SELLAS Life Sciences Group (SLS), and JATT Acquisition (JATT).

HealthCor Catalio Acquisition vs.

HealthCor Catalio Acquisition (NASDAQ:HCAQ) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking.

Check-Cap received 370 more outperform votes than HealthCor Catalio Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
HealthCor Catalio AcquisitionN/AN/A
Check-CapOutperform Votes
370
63.25%
Underperform Votes
215
36.75%

In the previous week, Check-Cap had 5 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 5 mentions for Check-Cap and 0 mentions for HealthCor Catalio Acquisition. Check-Cap's average media sentiment score of 0.58 beat HealthCor Catalio Acquisition's score of 0.00 indicating that Check-Cap is being referred to more favorably in the news media.

Company Overall Sentiment
HealthCor Catalio Acquisition Neutral
Check-Cap Positive

Company Net Margins Return on Equity Return on Assets
HealthCor Catalio AcquisitionN/A N/A N/A
Check-Cap N/A N/A N/A

84.2% of HealthCor Catalio Acquisition shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthCor Catalio AcquisitionN/AN/AN/AN/AN/A
Check-CapN/AN/A-$17.57M-$3.00-0.28

Summary

Check-Cap beats HealthCor Catalio Acquisition on 4 of the 5 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCAQ vs. The Competition

MetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ Exchange
Market Cap$19.84M$13.70B$5.22B$8.94B
Dividend YieldN/A1.83%4.98%4.03%
P/E RatioN/A23.45124.8816.69
Price / SalesN/A10.541,276.9391.02
Price / CashN/A13.1938.8936.42
Price / BookN/A2.526.395.98
Net IncomeN/A$273.70M$118.47M$225.08M

HealthCor Catalio Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCAQ
HealthCor Catalio Acquisition
N/A$0.87
-7.5%
N/A-19.0%$18.45MN/A0.002Gap Up
High Trading Volume
CHEK
Check-Cap
1.0664 of 5 stars
$1.00
-7.4%
N/A-76.5%$6.73MN/A-0.3380Short Interest ↓
News Coverage
High Trading Volume
GEHC
GE HealthCare Technologies
4.4689 of 5 stars
$85.94
-2.7%
N/A+20.2%$39.26B$19.55B23.6151,000Short Interest ↓
High Trading Volume
HOLX
Hologic
4.8889 of 5 stars
$78.76
-0.7%
N/A+10.9%$18.29B$4.03B23.656,990Analyst Upgrade
Short Interest ↓
Analyst Revision
BFLY
Butterfly Network
2.2186 of 5 stars
$2.62
+6.9%
N/A+141.2%$558.22M$65.90M-5.70460
NNOX
Nano-X Imaging
2.2718 of 5 stars
$6.10
+2.2%
N/A+8.3%$352.46M$9.90M-6.16190Upcoming Earnings
News Coverage
High Trading Volume
ALXO
ALX Oncology
3.4821 of 5 stars
$1.45
-4.0%
N/A-84.1%$80.59MN/A-0.4040Analyst Forecast
Short Interest ↓
Analyst Revision
EPIX
ESSA Pharma
3.0706 of 5 stars
$1.80
+1.7%
N/A-60.7%$79.86MN/A-2.9050Gap Up
AVTE
Aerovate Therapeutics
1.7111 of 5 stars
$2.72
-0.7%
N/A-78.7%$79.68MN/A-0.8751Short Interest ↓
Positive News
SLS
SELLAS Life Sciences Group
1.3462 of 5 stars
$1.23
+6.0%
N/A+44.3%$79.13M$1M-1.3416Short Interest ↑
News Coverage
JATT
JATT Acquisition
N/A$4.58
+2.5%
N/A+5.8%$79.01MN/A0.003High Trading Volume

Related Companies and Tools


This page (NASDAQ:HCAQ) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners